Novo Nordisk is the company that owns Ozempic. Ozempic is a drug used to treat type 2 diabetes and is also used off-label for weight loss. Novo Nordisk is a pharmaceutical company that specializes in diabetes care and has other drugs in its portfolio, including Rybelsus and Wegovy, which are also semaglutide-based drugs.